Risk Factors and Outcome of Recurrent Ischemic Stroke-A Prospective Study in a Tertiary Care Hospital
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2018, Vol 6, Issue 11
Abstract
Abstract: Cerebrovascular disease CVD is the most common disease group among all the neurological diseases. The prevalence of strokes in India is increasing as found in community-based studies. We in the present study tried to evaluate the risk factors and outcomes of recurrent ischemic stroke in patients presented to our tertiary care hospital. Methods: This study was conducted at Prathima Institute of Medical Sciences a tertiary care hospital located in Nagunoor, Karimnagar. 100 consecutive cases admitted under Arogyasri scheme with first recurrent ischemic stroke are included in this study. A modified Rankin Scale was used to assess the outcome of the first recurrent ischemic stroke patients and also analyze various risk factors of recurrent ischemic stroke with reference to history, symptomatology, and investigations. Out of the 100 patients admitted during the study 22 were lost during follow up and 5 developed another recurrent stroke within three months of follow up and all these were excluded from the study and 73 patients were taken for evaluation and statistical analysis. Results: The mean age for men was 58.06 years women were 62.52 years the total number of the male in our study was 38 (52.1%) and the female was 35(47.9%). Out 73 studied Out of 73 16 (21.9%) were with hypertension and 6 (8.2%) were diabetic, 19(26%) were smokers and 9 (12.3%) were only alcoholic 7(9.5%) were both and 38 (52.1%) had no addictions. During the recurrent stroke 39(53.4%) patients had the weakness (hemiparesis or hemiplegia or monoparesis or monoplegia) as the only presentation, 10(13.6%) patients had both weakness and facial palsy as their presentation, 16(21.9%) of patients had both weakness and aphasia as their presentation. At the third follow up after second stroke every patient some disability (MRS 1-5) on comparison of the patients with their residual weakness and weakness at the third follow up 21(28.7%) patients had MRS 1 as their residual disability and 10(13.6%) patients had MRS 1 as their disability at follow up. Conclusion: it can be concluded that the risk factors and outcome of RIS in this study were comparable with other similar studies. The important risk factors were hypertension, diabetes mellitus, smoking, atrial fibrillation and decreased compliance with the treatment. Therefore an improvement in patient adherence to treatment is a single very important factor in addition to optimal treatment and follow-up in decreasing the incidence of RIS.
Authors and Affiliations
Dr. Ranjith Kumar Polusani, Dr. K. Swapna Reddy
Keywords
Related Articles
- EP ID EP479739
- DOI -
- Views 67
- Downloads 0
Bioactive Materials: A Comprehensive Review
Bioactive materials have evolved over the past three decades from relatively specialized, highly biocompatible, but low-strength dental materials to new compositions for expanded use in restorative dentistry. The objecti...
Determinants of Immunization: A Study from Uttar Pradesh using Multinomial logistic Regression Approach
The objective is to examine socio-economic and demographic factors influencing partial and non-immunization of children in Uttar Pradesh. Data for this study was taken from National Family Health Survey (NFHS- 3). The un...
Epidemiologic and pathologic indices of gastric cancer in Kermanshah province, Iran
Gastric cancer is the second prevalent cancer and the second reason of death caused by cancer in the world. The aim of this study was to identify the epidemiologic and pathologic characteristics of gastric cancer in pati...
Normative Values of Pinch Strength in Pune- India Population
Abstract: Normative data published for pinch strength is available for many countries but as there are genetic, nutritional, environmental etc. variations in different regions it is necessary to find out normative data f...
Comparison of Dexmedetomidine or Buprenorphine as an Adjuvant to Levo-Bupivacaine in Spinal Anaesthesia for Lower Limb Surgeries
Abstract: Buprenorphine or dexmedetomidine used as adjuvant with 0.5% levo bupivacaine intrathecal to prolong the duration of analgesia. Eighty patients were randomly allocated to two groups, Group B received 60μg of bup...